COMPANY OVERVIEW

Cortice Biosciences, Inc. is a clinical-stage drug development company developing novel therapies for oncologic and neurologic disease indications with urgent unmet medical need.

---

LOCATION

New York, NY, USA

---

THERAPEUTIC AREAS

Neurological DIsorders

---

WEBSITE

https://www.corticebiosciences.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

May 18, 2017

Cortice Biosciences Announces an Upcoming Presentation at the 2017 American Society of Clinical Oncology Annual Meeting

Nov 20, 2015

Cortice Biosciences Announces Updated Results From Clinical Trials Evaluating TPI 287 for Treatment of Brain Malignancies

Jul 8, 2015

Cortice Biosciences Announces Issuance of a Key Patent Covering the Company's Alzheimer's Disease Drug Development Program

Apr 21, 2015

Cortice Biosciences Announces Updated Results From a Phase 1/2 Clinical Trial Evaluating TPI 287 for Treatment of Recurrent Glioblastoma

For More Press Releases

---